Genetic cure for muscular dystrophy 'a step closer': Treatment for muscle-wasting disease is possible, scientists say
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 19 August 1993
Scientists believe the animal experiments show that gene therapy - injecting healthy genes into patients - for muscular dystrophy is now more than a theoretical possibility, although researchers emphasise in today's issue of the journal Nature that more work needs to be done.
Duchenne muscular dystrophy affects about one in every 3,500 boys and is one of the most common genetic diseases with no cure. Females rarely develop the symptoms but can be carriers. The signs of muscle wasting first appear at about three years old. Children are often confined to wheelchairs by the age of 11 and develop severe respiratory and heart problems that frequently prove lethal by their mid-twenties.
Ever since the gene for muscular dystrophy was discovered in 1986, scientists have thought that gene therapy could provide a cure, but the problems of inserting such a large gene - it is 100 times the size of a typical gene - into all affected muscle cells seemed insurmountable.
Jeffrey Chamberlain, assistant professor of human genetics at the University of Michigan Medical School, United States, who led the research team, said the work demonstrated for the first time that a cure was possible: 'We have clearly shown that if you can get the gene into the muscle you can cure the disease.'
He warned that the method used to cure the mice could not be used on humans because genetic manipulation of the very early embryo was too dangerous. 'If you can find an effective way to get the gene into humans, and you can control it properly, then you may have a cure. In this study we found a way to control the gene once it's in the muscle; now we need to find a way to deliver it (to muscles).'
Dr Chamberlain's group is attempting to insert the healthy gene into the influenza virus which can then be used to 'infect' muscle cells of the lungs with the correct gene form.
Kay Davies, a medical geneticist who will soon become head of the Medical Research Council's new Clinical Research Centre at Hammersmith, London, and who helped to discover the muscular dystrophy gene, said at the International Congress of Genetics at Birmingham yesterday that Dr Chamberlain's work showed that such gene therapy does not produce toxic side-effects.
'It's a very important experiment (because) we need to know what range of toxicity there might be,' she said. 'This is a valuable contribution but we still have a long way to go before we get a method that is efficient at getting at all the respiratory cells.'
Although muscular dystrophy is inherited, about a third of cases result from spontaneous mutations in early life, so pre-natal diagnosis cannot eliminate it completely, which is why gene therapy is important.
Gods who sell our genes, page 32
By performing as African Americans or Indians, white people get to play act a kind of 'imaginary liberation', writes Michael Mark Cohen
New essay by JK Rowling went live on Pottermore site this morning
New UK station Russia Today gives a very bizarre view of Britain
Top Gear presenter is no stranger to foot-in-mouth controversy
- 1 Canadian actor punched in face after 'Islamophobia' experiment goes wrong in wake of Ottawa shooting
- 2 Topshop at centre of row over body image as 'shocking' skinny mannequin photo goes viral
- 3 Top Gear presenter Jeremy Clarkson criticised for beer tweet
- 4 The bubble bursts for Sodastream
- 5 If you think Russell Brand’s new book is confused, you should read what his critics have to say about it
'Nasa Confirms Six Days of Darkness in December': No, they don't - it's a hoax
Top Gear presenter Jeremy Clarkson criticised for beer tweet
The bubble bursts for Sodastream
Russian politician says Apple CEO Tim Cook should be 'banned' from country after coming out as gay
'Santa Claus' dead: John Moore starred in Coca Cola and Morrisons adverts
Pope Francis declares evolution and Big Bang theory are real and God is not 'a magician with a magic wand'
Huge surge in Ukip support after EU funding row, according to new poll
Ukip ‘exploiting grooming scandal’ to secure party’s first police chief
Nigel Farage: 'There’s nothing wrong with white people blacking up'
Maureen Lipman says 'she can't vote Labour while Ed Miliband is leader'
Muslims, immigration and teenage pregnancy: British people are ignorant about almost everything
£40000 - £65000 per annum + bonus + benefits + OT: Ampersand Consulting LLP: M...
£22800 - £33600 per annum: Randstad Education Manchester Secondary: The JobAt ...
£22800 - £33600 per annum: Randstad Education Manchester Secondary: Calling al...
£100 - £125 per day: Randstad Education Chelmsford: EYFS Teachers - East Essex...